Cypress Capital LLC Has $1.99 Million Stock Position in Lam Research Corporation $LRCX

Cypress Capital LLC lessened its holdings in shares of Lam Research Corporation (NASDAQ:LRCX) by 32.4% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 14,824 shares of the semiconductor company’s stock after selling 7,089 shares during the period. Cypress Capital LLC’s holdings in Lam Research were worth $1,985,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of LRCX. IMG Wealth Management Inc. acquired a new position in Lam Research during the 2nd quarter worth about $26,000. Howard Hughes Medical Institute bought a new position in shares of Lam Research during the second quarter worth about $27,000. Strategic Wealth Investment Group LLC acquired a new position in shares of Lam Research in the second quarter worth approximately $29,000. Delos Wealth Advisors LLC acquired a new position in shares of Lam Research in the second quarter worth approximately $30,000. Finally, REAP Financial Group LLC bought a new stake in Lam Research in the second quarter valued at approximately $31,000. Institutional investors own 84.61% of the company’s stock.

Trending Headlines about Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Analysts and the market have spotlighted Lam’s AI‑focused wafer‑processing tools, driving heavy buying interest and helping lift the stock in recent sessions. Lam Research (LRCX) Is Up 19.1% After Analysts Spotlight Its AI-Focused Chipmaking Tools
• Positive Sentiment: Wall Street coverage remains constructive: multiple recent buy/overweight ratings and price targets reflect continued analyst bullishness on secular AI and cloud demand for Lam’s equipment. Lam Research Corporation Stock (LRCX) Opinions on Recent ‘Buy’ Rating and AI Demand
• Positive Sentiment: Longer‑term research pieces continue to rate LRCX as a top semiconductor equipment name based on revenue/earnings momentum and AI tailwinds. These narratives support investor conviction despite higher multiples. Why Lam Research (LRCX) is a Top Stock for the Long-Term
• Neutral Sentiment: Lam scheduled its December‑quarter earnings call for Jan. 28 — an event that will likely be the next major catalyst (guidance, backlog and AI demand commentary are key). Lam Research Corporation Announces December Quarter Financial Conference Call
• Neutral Sentiment: Coverage pieces debating whether LRCX remains attractive after a ~153% one‑year run highlight valuation and momentum trade considerations — useful context but not immediate catalysts. Is Lam Research (LRCX) Still Attractive After A 153% One Year Share Price Surge
• Negative Sentiment: Today’s pullback outpaced the broader market — Zacks notes a decline versus the prior session, consistent with short‑term profit‑taking after the recent rally. Why Lam Research (LRCX) Dipped More Than Broader Market Today
• Negative Sentiment: Significant insider selling (multiple senior exec sales reported) and some institutional rebalancing have been noted — these can create added near‑term selling pressure or signal opportunistic profit‑taking. Lam Research Corporation Stock (LRCX) Opinions on Recent ‘Buy’ Rating and AI Demand

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on LRCX. Needham & Company LLC boosted their price target on shares of Lam Research from $150.00 to $160.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. UBS Group restated a “buy” rating and issued a $200.00 target price (up previously from $175.00) on shares of Lam Research in a report on Tuesday, December 23rd. Barclays set a $142.00 price target on shares of Lam Research and gave the company an “equal weight” rating in a research report on Monday, October 20th. Jefferies Financial Group reissued a “buy” rating and issued a $200.00 price objective (up from $175.00) on shares of Lam Research in a research report on Monday, December 15th. Finally, The Goldman Sachs Group boosted their price objective on Lam Research from $115.00 to $160.00 and gave the company a “buy” rating in a research note on Wednesday, October 8th. Twenty-six equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $161.21.

Lam Research Stock Performance

NASDAQ LRCX opened at $203.18 on Thursday. The company has a market cap of $255.19 billion, a P/E ratio of 44.75, a PEG ratio of 2.39 and a beta of 1.77. The company has a fifty day simple moving average of $163.98 and a 200 day simple moving average of $131.44. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a 12-month low of $56.32 and a 12-month high of $210.45.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The business’s quarterly revenue was up 27.7% compared to the same quarter last year. During the same period last year, the firm earned $0.86 earnings per share. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Sell-side analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd were paid a $0.26 dividend. The ex-dividend date of this dividend was Wednesday, December 3rd. This represents a $1.04 annualized dividend and a dividend yield of 0.5%. Lam Research’s dividend payout ratio is 22.91%.

Insider Buying and Selling

In related news, CFO Douglas R. Bettinger sold 40,080 shares of the company’s stock in a transaction on Friday, November 14th. The stock was sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the completion of the sale, the chief financial officer owned 987,237 shares in the company, valued at approximately $148,677,892.20. This represents a 3.90% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Vahid Vahedi sold 52,190 shares of the stock in a transaction on Monday, October 13th. The shares were sold at an average price of $138.90, for a total value of $7,249,191.00. Following the completion of the sale, the senior vice president directly owned 251,047 shares of the company’s stock, valued at $34,870,428.30. The trade was a 17.21% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 102,608 shares of company stock valued at $14,916,496. 0.31% of the stock is owned by company insiders.

Lam Research Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.